BIOVIE INC. — Investor Relations & Filings
BioVie Inc. is a clinical-stage biopharmaceutical company that develops drug therapies for chronic debilitating conditions. The company's pipeline focuses on neurological and neurodegenerative disorders as well as advanced liver disease. Its lead drug candidate, bezisterim, is being studied for Alzheimer's disease based on the hypothesis that modulating inflammation and enhancing insulin sensitivity in the brain can improve cognitive function and provide neuroprotection. Other areas of focus include Parkinson's disease, ascites (a common complication of advanced liver cirrhosis), and Long COVID. The company also conducts research into epigenetic mechanisms, such as DNA methylation, to understand gene expression regulation.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Regulatory Filings 2025 | 2025-05-15 | English | |
| Regulatory Filings 2025 | 2025-05-15 | English | |
| FORM 10-Q FOR PERIOD ENDING MARCH 31, 2025 | 2025-05-12 | English | |
| PRE 14C | 2025-05-08 | English | |
| PRE 14C | 2025-05-07 | English | |
| CURRENT REPORT | 2025-03-28 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 12689167 | Regulatory Filings 2025 | 2025-05-15 | English | ||
| 12689166 | Regulatory Filings 2025 | 2025-05-15 | English | ||
| 12689168 | FORM 10-Q FOR PERIOD ENDING MARCH 31, 2025 | 2025-05-12 | English | ||
| 12689169 | PRE 14C | 2025-05-08 | English | ||
| 12689170 | PRE 14C | 2025-05-07 | English | ||
| 12689171 | CURRENT REPORT | 2025-03-28 | English | ||
| 12689172 | Major Shareholding Notification 2025 | 2025-02-12 | English | ||
| 12689173 | FORM 10-Q FOR PERIOD ENDING DECEMBER 31, 2024 | 2025-02-11 | English | ||
| 12689174 | Director's Dealing 2025 | 2025-01-07 | English | ||
| 12689175 | Director's Dealing 2025 | 2025-01-07 | English | ||
| 12689176 | Director's Dealing 2025 | 2025-01-07 | English | ||
| 12689177 | Director's Dealing 2025 | 2025-01-07 | English | ||
| 12689178 | Director's Dealing 2025 | 2025-01-07 | English | ||
| 12689179 | Director's Dealing 2025 | 2025-01-07 | English | ||
| 12689180 | Director's Dealing 2025 | 2025-01-07 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
BIOVIE INC. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35090/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35090 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35090 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35090 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35090}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for BIOVIE INC. (id: 35090)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.